% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Roohani:306534,
author = {S. Roohani$^*$ and P. W. M. Chung and B. C. Dickson and P.
C. Ferguson and A. M. Griffin and D. G. Kirsch and R. Krcek
and B. O'Sullivan and D. B. Shultz and K. M. Tsoi and P.
Wong and J. S. Wunder and C. N. Catton},
title = {{R}efining surveillance in {M}yxoid liposarcoma: long-term
recurrence patterns and functional outcomes after surgery ±
radiotherapy in 186 patients.},
journal = {Radiotherapy and oncology},
volume = {214},
issn = {0167-8140},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {DKFZ-2025-02599},
pages = {111275},
year = {2026},
note = {Volume 214, January 2026, 111275},
abstract = {To assess oncologic, functional outcomes, and recurrence
patterns in a large cohort of prospectively collected
patients with localized extremity/trunk myxoid liposarcoma
with long-term follow-up.Analysis of 186 patients
(1992-2025) treated with surgery ± perioperative
radiotherapy. Data were drawn from prospective institutional
registries with central pathology/radiology review.wound
complications, late toxicity, functional scores, overall
survival (OS), cancer-specific survival (CSS), and local
(LR) and distant metastatic recurrence (DM).Median age was
44.5 years; median follow-up 77 months. All had surgery;
86.6 $\%$ received radiotherapy (73.7 $\%$ preoperatively).
Wound complications occurred in 33.3 $\%.$ Late ≥ Grade 2
toxicities: skin (7.5 $\%),$ subcutaneous fibrosis (14.5
$\%),$ joint stiffness (2.2 $\%),$ edema (9.1 $\%).$
Functional scores at last follow-up: median TESS: 97 (mean
91.3), MSTS-87: 35 (mean 33.1), MSTS-93: 100 (mean 94.7).
LR: 3 cases (1.6 $\%,$ 5-year cumulative incidence: 1.4
$\%).$ DM: 31 patients (16.7 $\%),$ involving 40 sites (42.5
$\%$ soft tissue, 22.5 $\%$ lung, 17.5 $\%$ bone, 7.5 $\%$
liver, 5 $\%$ lymph nodes). Cumulative incidence of DM:
1-year 0.6 $\%,$ 5-year 10.8 $\%,$ 10-year 23.4 $\%.$ CSS
was 100 $\%,$ 96.4 $\%,$ and 80 $\%$ at 1, 5, and 10 years,
respectively. OS was 98.8 $\%,$ 92 $\%,$ and 74.2 $\%$ at
the same time points.Local control was high, and long-term
function were favorable. Distant recurrences were more
frequent, occurred at a constant rate beyond 5 years,
without plateau, often involved extra-pulmonary sites, and
drove late cancer-related mortality. These findings support
the consideration of continued annual follow-up through at
least 10 years, with imaging of pulmonary and
extra-pulmonary sites to adequately capture the full
spectrum of metastatic risk.},
keywords = {Cohort study (Other) / Distant failure (Other) /
Extremities (Other) / MSTS (Other) / RTOG (Other) / Soft
tissue sarcoma (Other) / TESS (Other) / Toxicity (Other) /
Trunk wall (Other)},
cin = {BE01},
ddc = {610},
cid = {I:(DE-He78)BE01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41275974},
doi = {10.1016/j.radonc.2025.111275},
url = {https://inrepo02.dkfz.de/record/306534},
}